SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : SEVU: New Invention of Great Potential...

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LaShark who wrote (1489)2/13/2001 2:21:47 PM
From: StockDung  Read Replies (2) of 1992
 
FTC conducting inquiry into BioPulse advertising

WASHINGTON, Feb 13 (Reuters) - The Federal Trade Commission in conducting an inquiry into BioPulse International Inc.'s (OTC BB:BIOP.OB - news) advertising of health-care products and treatments, the biotechnology company said on Tuesday.

The purpose of the probe ``is to determine whether we have engaged in unfair or deceptive acts or practices, including whether we can substantiate claims we have made relating to treatments for cancer and other diseases,'' BioPulse said in a filing with the Securities and Exchange Commission.

The company said it received a letter from the FTC on Feb. 2 notifying it of the probe.

BioPulse, which is seeking treatments for cancer and other diseases, quoted the FTC as saying the inquiry should not be viewed as an accusation of wrongdoing.

BioPulse President Loran Swensen did not immediately return a telephone call seeking further comment. A company spokesman, John Liviakis, said, ``I didn't get the impression it (the FTC inquiry) was anything major.''

Shares of San Diego-based BioPulse were down 1/16 to $5-7/16 in afternoon trade on the Bulletin Board. The stock has a 52-week high of $12-1/8 and a low of $2.

xxxxxxxxxxxxxxxxxxx
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext